MIAMI / Oct 01, 2023 / Business Wire / CarePlus Health Plans, Inc., a recognized leader in healthcare delivery that has been offering Medicare Advantage health plans in Florida for over 23 years, announced that in 2024 the company is adding a new “dental allowance” benefit on many plans.
The announcement follows a recent expansion of the number of dentists available to its members across Florida. In addition, the company’s 2024 Medicare Advantage plans for Floridians eligible for both Medicare and Medicaid will include help paying for living expenses, such as groceries, rent and utilities.
“Every year, we carefully consider how the plans we offer can meet the different needs of our current and future members across Florida,” said CarePlus President Steven Ruiz. “For 2024, I’m pleased to share that we’re expanding our commitment to put spending power back in CarePlus members’ pockets by providing our popular Part B premium giveback benefit on more than 60% of our Medicare Advantage plans. At the same time, members will enjoy expanded dental service thanks to our recent network expansion and trusted dental provider partners.”
New for 2024
Also Included on Most CarePlus Medicare Advantage Plans
Florida residents seeking more information about enrolling in a CarePlus Medicare Advantage health plan can visit www.CarePlusHealthPlans.com, es-www.CarePlusHealthPlans.com (SP) or speak with a licensed CarePlus sales agent by calling 1-855-450-1352 (TTY: 711).
CarePlus currently serves approximately 200,000** Medicare members throughout Florida.
About CarePlus Health Plans
CarePlus Health Plans strives to help Florida Medicare beneficiaries achieve their best possible health and wellness. Our Medicare Advantage plans help people with Medicare, or both Medicare and Medicaid, get the benefits and services they care about.
CarePlus is also an ACCESS Florida Department of Children and Families community partner. That means we can provide access to public assistance services such as helping people apply for financial assistance through a variety of state and federal programs including Medicaid, Extra Help, Temporary Cash Assistance Programs or the Supplemental Nutrition Assistance Program (SNAP).
Together with our trusted network doctors and healthcare providers, we are pleased to serve our communities with care. For more information, visit CarePlusHealthPlans.com.
*The amount may change based on the amount you pay for Part B.
**According to the Centers for Medicare & Medicaid Services (CMS) Medicare Advantage (MA) Membership Reports, September, 2023.
CarePlus is an HMO SNP plan with a Medicare contract and a contract with the Florida Medicaid Program. Enrollment in CarePlus depends on contract renewal. CareNeeds Plus (HMO D-SNP) and CareNeeds Platinum (HMO D-SNP) are available to anyone receiving both Medicare and Medicaid: Qualified Medicare Beneficiaries (QMB/QMB+), Specified Low-Income Medicare Beneficiaries (SLMB/SLMB+), Qualifying Individuals (QI), Qualified Disabled and Working Individuals (QDWI) and other Full Benefit Dual Eligibles (FBDE). CareBreeze Platinum (HMO C-SNP) is available to anyone enrolled in Medicare with a diagnosis of chronic lung disorders. CareComplete Platinum (HMO C-SNP) is available to anyone enrolled in Medicare with a diagnosis of diabetes, cardiovascular disorders or chronic heart failure. Referrals and/or authorization may be required for certain specialists. Consult your doctor before beginning any new diet or exercise regimen. In accordance with the federal requirements of the Centers for Medicare & Medicaid Services (CMS), no amounts on the gift cards shall be redeemable for cash and no amount may be applied toward the purchase of any prescription drug under your plan. Rewards (gift cards) must be earned and redeemed in the same plan year. Rewards not redeemed by 12/31 will be forfeited.
Last Trade: | US$357.86 |
Daily Change: | -7.28 -1.99 |
Daily Volume: | 920,436 |
Market Cap: | US$43.090B |
August 19, 2024 August 08, 2024 July 31, 2024 July 25, 2024 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORECue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB